Swiss investment company BB Biotech reported an outstanding third quarter in 2025. Here’s why.

War, crises, and capital flows: the global rearmament boom is transforming not only the security landscape but also the ...

Mike Pompeo, former 70th U.S. Secretary of State under the first Trump administration and a self-proclaimed hardliner, set ...

UBS Vice Chairman of the Board of Directors Lukas Gähwiler (60) is unexpectedly stepping down. He will leave UBS in the ...

Swiss entrepreneur reflects on a decade of building Decalia from scratch into one of Geneva’s leading independent asset ...

The Family Barometer 2025 by Julius Bär and PwC seeks to highlight current trends among UHNW families when it comes to ...

Blockstream Capital Partners has acquired Zug-based Berglinde, a boutique specializing in Bitcoin-backed lending. The firm ...

Swiss chief financial officers' assessments of the country's business outlook for the next three years have recovered from ...

Swiss Life Asset Managers aims to strengthen its relationships with clients and has created a new division, Marketing & ...

In a stunning rebuke to Switzerland’s financial regulators, the Federal Administrative Court has ruled that the forced ...

For the first time, the Swiss National Bank (SNB) has published a summary of the discussion held by its Governing Board ...